Advanced Resin Therapeutics Email Formats
Pharmaceutical Manufacturing • 
San Francisco, California, United States • 1-10 Employees
Key Contact at Advanced Resin Therapeutics
Howard Edelman
CEO
Company overview
| Headquarters | 2116 15th Avenue, San Francisco, CA 94116, US |
| Website | |
| NAICS | 3254 |
| SIC | 283 |
| Keywords | Medical Devices, Specialty Pharmaceutical Company, Patented Resin-Based Drug Delivery System |
| Founded | 2016 |
| Employees | 1-10 |
About Advanced Resin Therapeutics
Advanced Resin Therapeutics is a specialty pharmaceutical company that has developed a novel, resin-based, drug delivery system that promotes topical and transmucosal delivery of medications more efficiently and effectively than current technologies. The company has grown its IP portfolio to include 11 issued patents worldwide and 28 pending patents. Clinical trial results confirm quick, safe, and prolonged delivery of medications for both its topical and transmucosal product lines. Since its inception, the Company has brought in $5M in licensing revenue, and now has two market-ready products and two clinical stage products. In addition, the company has distribution agreements in place for its post-operative topical product (Mastisol® Plus) in the U.S. surgical adhesive marketplace. ART’s lead product opportunity is NicoSwab™, a highly innovative, fast-acting, long-lasting nicotine replacement product.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
Advanced Resin Therapeutics has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
Advanced Resin Therapeutics has never raised funding before.
Hong Kong
Germany
New Zealand
Canada
United KingdomFrequently asked questions
4.8
40,000 users
